ICQC response to Health Canada evaluation of GI claims

Jenkins Dj; Willett Wc; Arne Astrup; Augustin Ls; S. Baer Sinnott; Barclay Aw; Inger Björck; Brand Miller Jc; Furio Brighenti; Buyken Ae; Antonio Ceriello; Kendall Cw; Carlo La Vecchia; Geoff Livesey; Simin Liu; Albino Poli; Gabriele Riccardi; Rizkalla Sw; Sievenpiper Jl; Antonia Trichopoulou; Wolever Tm

Letter2013

Glycaemic index: did Health Canada get it wrong? Position from the International Carbohydrate Quality Consortium (ICQC)

David J.A. Jenkins, Walter C. Willett, Arne Astrup, Livia S. A. Augustin, Sara Baer-Sinnott, Alan W. Barclay, Inger Björck, Jennie Brand‐Miller, Furio Brighenti, Anette E. Buyken, Antonio Ceriello, Cyril W.C. Kendall, Carlo La Vecchia, Geoffrey Livesey, Simin Liu, Andrea Poli, Gabriele Riccardi, Salwa W. Rizkalla, John L. Sievenpiper, Antonia Trichopoulou, Thomas M.S. Wolever

Article2009

Response to “unsupported claims of ultrafast charging of Li-ion batteries”

Gerbrand Ceder, Byoungwoo Kang

Article2009

Response to “Unsupported Claims of Ultrafast Charging of Li-ion Batteries”

Gerbrand Ceder, Byoungwoo Kang

Article1993

Health-risk perception in Canada

Paul Slovic, James Flynn, C. K. Mertz, Lindsay A. Mullican

Article2023

EVALUATION OF EFFECTIVENESS AND SAFETY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS WHO SWITCHED FROM WARFARIN TO DIRECT ORAL ANTICOAGULANTS FROM MULTIPLE HEALTH CARE CLAIMS DATABASES

Professor Gregory Lip, Virginia Noxon, Amiee Kang, Xuemei Luo, Nipun Atreja, Stella Han, Dong Cheng, Jenny Jiang, Lisa Abramovitz, Steven Deitelzweig

ICQC response to Health Canada evaluation of GI claims

Discussion(0)

Related publications

Glycaemic index: did Health Canada get it wrong? Position from the International Carbohydrate Quality Consortium (ICQC)

Response to “unsupported claims of ultrafast charging of Li-ion batteries”

Response to “Unsupported Claims of Ultrafast Charging of Li-ion Batteries”

Health-risk perception in Canada

EVALUATION OF EFFECTIVENESS AND SAFETY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS WHO SWITCHED FROM WARFARIN TO DIRECT ORAL ANTICOAGULANTS FROM MULTIPLE HEALTH CARE CLAIMS DATABASES